<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23541879</identifier>
<setSpec>1578-1852</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Rivero, Antonio</dc:author>
<dc:author>Iribarren, José A</dc:author>
<dc:author>Miró, José M</dc:author>
<dc:author>Pulido, Federico</dc:author>
<dc:author>Moreno, Santiago</dc:author>
<dc:author>Caylá, Joan</dc:author>
<dc:author>Pérez-Camacho, Inés</dc:author>
<dc:description xml:lang="en">This consensus document was prepared by an expert panel of the Grupo de Estudio de Sida (GESIDA [Spanish AIDS Study Group]) and the Plan Nacional sobre el Sida (PNS [Spanish National AIDS Plan]). The document updates current guidelines on the treatment of tuberculosis (TB) in HIV-infected individuals contained in the guidelines on the treatment of opportunistic infections published by GESIDA and PNS in 2008. The document aims to facilitate the management and treatment of HIV-infected patients with TB in Spain, and includes specific sections and recommendations on the treatment of drug-sensitive TB, multidrug-resistant TB, and extensively drug-resistant TB, in this population. The consensus guidelines also make recommendations on the treatment of HIV-infected patients with TB in special situations, such as chronic liver disease, pregnancy, kidney failure, and transplantation. Recommendations are made on the timing and initial regimens of antiretroviral therapy in patients with TB, and on immune reconstitution syndrome in HIV-infected patients with TB who are receiving antiretroviral therapy. The document does not cover the diagnosis of TB, diagnosis/treatment of latent TB, or treatment of TB in children. The quality of the evidence was evaluated and the recommendations graded using the approach of the Grading of Recommendations Assessment, Development and Evaluation Working Group.</dc:description>
<dc:type>Consensus Development Conference</dc:type>
<dc:language>es</dc:language>
<dc:subject>Multidrug-resistant tuberculosis</dc:subject>
<dc:subject>Tuberculosis</dc:subject>
<dc:subject>Tratamiento antirretroviral</dc:subject>
<dc:subject>Antituberculous therapy</dc:subject>
<dc:subject>Extensively drug-resistant tuberculosis</dc:subject>
<dc:subject>Tuberculosis multirresistente</dc:subject>
<dc:subject>Fármacos antituberculosos</dc:subject>
<dc:subject>Human immunodeficiency virus</dc:subject>
<dc:subject>Anti-retroviral treatment</dc:subject>
<dc:subject>Virus de la inmunodeficiencia humana</dc:subject>
<dc:subject>Tuberculosis con resistencia extendida</dc:subject>
<dc:date>2013 Dec </dc:date>
<dc:title xml:lang="es">Recomendaciones de GESIDA/Secretaría del Plan Nacional sobre el Sida para el tratamiento de la tuberculosis en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero de 2013).</dc:title>
<dc:title xml:lang="en">[The Spanish AIDS Study Group and Spanish National AIDS Plan (GESIDA/Secretaría del Plan Nacional sobre el Sida) recommendations for the treatment of tuberculosis in HIV-infected individuals (Updated January 2013)].</dc:title>
<dc:publisher>Enfermedades infecciosas y microbiologia clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
